Healthcare Providers

Log into the REMS portal to complete certification in the program. Once certified, use the portal to manage REMS tasks and patients.

Healthcare Provider Login

NOTE: This portal cannot be opened in Internet Explorer (IE) or the legacy version of Microsoft Edge available before 2020. The portal can be opened in the version of Microsoft Edge available in January 2020. You can also copy and paste the link into a different browser.

CAMZYOSTM is only available through the CAMZYOS REMS. In order for healthcare providers to prescribe CAMZYOS, they must become
certified in the REMS.

To become certified in the CAMZYOS REMS, healthcare providers must:

1.Complete the CAMZYOS REMS training program, which includes reviewing the following materials:

2.Successfully complete the Healthcare Provider Knowledge Assessment and submit it to the REMS.

3.Enroll by completing the Healthcare Provider Enrollment Form and submitting it to the REMS.

The CAMZYOS REMS will send confirmation of your enrollment in the CAMZYOS REMS. You will not be able to prescribe CAMZYOS without completing your certification in the CAMZYOS REMS. If you fail to comply with the CAMZYOS REMS requirements, you will no longer be certified in the CAMZYOS REMS.

Patient Management

Counseling before treatment:

Counseling before treatment:

Counsel the patient, using the Patient Brochure, on the:

  • Risk of heart failure due to systolic dysfunction, including how to recognize and respond to the symptoms of heart failure due to systolic dysfunction
  • Risk of drug-drug interactions with CYP2C19 and CYP3A4 inhibitors and inducers and the need to inform healthcare providers of all the prescription and nonprescription medications they take

Provide the patient with the Patient Brochure.

Assessments before treatment:

Assessments before treatment:

Assess the patient’s cardiovascular status and the appropriateness of initiating treatment by obtaining an echocardiogram. Additionally, assess the patient’s prescription and nonprescription medications and supplements for drug-drug interactions. Document confirmation of an echocardiogram, assessment of drug-drug interactions, and authorization for treatment using the Patient Enrollment Form. Enroll the patient by completing and submitting the Patient Enrollment Form to the REMS. Retain a copy for the patient’s medical record.

During treatment:

During treatment:

  • Assess the patient’s cardiovascular status, and the appropriateness of continuing treatment by obtaining echocardiograms at the frequency described in the Prescribing Information
  • Counsel the patient as described above
  • Assess the patient’s prescription and nonprescription medications and supplements for drug-drug interactions

Document and submit that the patient has been counseled, the echocardiogram has been performed, the patient’s medications have been assessed for drug-drug interactions, and it is appropriate to continue treatment using the Patient Status Form.

At all times:

At all times:

Report any adverse events of heart failure due to systolic dysfunction, including full details of the patient’s medical status and dose of CAMZYOS at the time of the event, to Bristol Myers Squibb

This website is best viewed
using the horizontal display
on your tablet device.

This website is best viewed
using the vertical display
on your mobile device.